JP2024518556A5 - - Google Patents

Info

Publication number
JP2024518556A5
JP2024518556A5 JP2023570167A JP2023570167A JP2024518556A5 JP 2024518556 A5 JP2024518556 A5 JP 2024518556A5 JP 2023570167 A JP2023570167 A JP 2023570167A JP 2023570167 A JP2023570167 A JP 2023570167A JP 2024518556 A5 JP2024518556 A5 JP 2024518556A5
Authority
JP
Japan
Prior art keywords
carboxamide
amino
cyclopropanamide
methylpyridazine
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023570167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518556A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/029105 external-priority patent/WO2022241172A1/en
Publication of JP2024518556A publication Critical patent/JP2024518556A/ja
Publication of JP2024518556A5 publication Critical patent/JP2024518556A5/ja
Pending legal-status Critical Current

Links

JP2023570167A 2021-05-14 2022-05-13 置換ヘテロ環化合物 Pending JP2024518556A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163188498P 2021-05-14 2021-05-14
US63/188,498 2021-05-14
US202263328835P 2022-04-08 2022-04-08
US63/328,835 2022-04-08
PCT/US2022/029105 WO2022241172A1 (en) 2021-05-14 2022-05-13 Substituted heterocyclic compounds

Publications (2)

Publication Number Publication Date
JP2024518556A JP2024518556A (ja) 2024-05-01
JP2024518556A5 true JP2024518556A5 (cg-RX-API-DMAC7.html) 2025-05-21

Family

ID=81928155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023570167A Pending JP2024518556A (ja) 2021-05-14 2022-05-13 置換ヘテロ環化合物

Country Status (5)

Country Link
US (1) US20240317718A1 (cg-RX-API-DMAC7.html)
EP (1) EP4337649A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024518556A (cg-RX-API-DMAC7.html)
KR (1) KR20240008339A (cg-RX-API-DMAC7.html)
WO (1) WO2022241172A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN122520625A (zh) 2020-12-22 2026-08-07 益方生物科技(上海)股份有限公司 杂芳基化合物及其制备方法和用途
US12668594B2 (en) 2020-12-23 2026-06-30 Sudo Biosciences Limited TYK2 inhibitors and uses thereof
IL305119A (en) 2021-02-19 2023-10-01 Sudo Biosciences Ltd Tyk2 inhibitors and uses thereof
TW202302583A (zh) 2021-02-19 2023-01-16 英商蘇多生物科學有限公司 Tyk2抑制劑及其用途
KR20230159421A (ko) 2021-02-19 2023-11-21 수도 바이오사이언시즈 리미티드 Tyk2 억제제 및 이의 용도
EP4337650A1 (en) * 2021-05-14 2024-03-20 Bristol-Myers Squibb Company Substituted heterocyclic compounds
KR20240008338A (ko) * 2021-05-14 2024-01-18 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물
KR20240007242A (ko) * 2021-05-14 2024-01-16 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물
CN117263913A (zh) 2022-06-20 2023-12-22 益方生物科技(上海)股份有限公司 杂芳基化合物、固体形式、制备方法及其用途
WO2024044486A1 (en) * 2022-08-22 2024-02-29 Ajax Therapeutics, Inc. Jak2 inhibitor compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20220766T1 (hr) * 2012-11-08 2022-09-16 Bristol-Myers Squibb Company Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora
JP7485609B2 (ja) * 2018-03-22 2024-05-16 ブリストル-マイヤーズ スクイブ カンパニー IL-12、IL-23および/またはIFNα応答のモジュレーターとして有用なピリジン含有ヘテロ環式化合物
KR102858043B1 (ko) * 2018-10-30 2025-09-10 브리스톨-마이어스 스큅 컴퍼니 Il-12, il-23 및/또는 ifn-알파의 조정과 관련된 상태의 치료를 위한 아미드-치환된 헤테로시클릭 화합물
KR102943760B1 (ko) * 2019-01-28 2026-03-26 장쑤 한서 파마슈티칼 그룹 캄파니 리미티드 피리다진 유도체 억제제, 및 그의 제조 방법 및 용도
JP7740849B2 (ja) * 2021-05-04 2025-09-17 シャンハイ ゼイ バイオテクノロジー カンパニー リミテッド 含窒素複素環ピリジン化合物
PE20250262A1 (es) * 2021-05-14 2025-01-29 Bristol Myers Squibb Co Compuestos heterociclicos sustituidos
EP4337650A1 (en) * 2021-05-14 2024-03-20 Bristol-Myers Squibb Company Substituted heterocyclic compounds
KR20240008338A (ko) * 2021-05-14 2024-01-18 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물
KR20240007242A (ko) * 2021-05-14 2024-01-16 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물

Similar Documents

Publication Publication Date Title
RU2018138707A (ru) Замещенные гетероарилом пиридины и способы применения
CN101410111B (zh) 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用
JP2019517455A5 (cg-RX-API-DMAC7.html)
JP6017313B2 (ja) 化合物および方法
AU2010302842B2 (en) Novel compounds
JP2007523142A5 (cg-RX-API-DMAC7.html)
KR101345497B1 (ko) 설폰아미드 유도체
DK2038265T3 (en) Inhibitors of human protein tyrosine phosphatase and methods of use
RU2392275C2 (ru) Бензамидные производные и их применение в качестве активирующих глюкокиназу агентов
JP2021504443A5 (cg-RX-API-DMAC7.html)
JP2008501673A5 (cg-RX-API-DMAC7.html)
CA2630269A1 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
RU2005129729A (ru) Производные гетероарилкарбамоилбензола
JP2010533158A5 (cg-RX-API-DMAC7.html)
JP2005513026A5 (cg-RX-API-DMAC7.html)
RU2009102537A (ru) Ингибиторы белок-тирозинфосфатазы человека и способы применения
JP2015517580A5 (cg-RX-API-DMAC7.html)
JP2007523905A5 (cg-RX-API-DMAC7.html)
RU2008110949A (ru) Соединения и композиции-иммуносупрессанты
JP2004502670A5 (cg-RX-API-DMAC7.html)
JP2014523400A5 (cg-RX-API-DMAC7.html)
AU2012245082A1 (en) Aromatic amides and uses thereof
JP2010540462A5 (cg-RX-API-DMAC7.html)
JP2013531070A5 (cg-RX-API-DMAC7.html)
JP2014513122A5 (cg-RX-API-DMAC7.html)